Literature DB >> 27061318

Clinical applications of MS-based protein quantification.

Bassel Sabbagh1, Sonani Mindt1, Michael Neumaier1, Peter Findeisen1,2,3.   

Abstract

Mass spectrometry-based assays are increasingly important in clinical laboratory medicine and nowadays are already commonly used in several areas of routine diagnostics. These include therapeutic drug monitoring, toxicology, endocrinology, pediatrics, and microbiology. Accordingly, some of the most common analyses are therapeutic drug monitoring of immunosuppressants, vitamin D, steroids, newborn screening, and bacterial identification. However, MS-based quantification of peptides and proteins for routine diagnostic use is rather rare up to now despite excellent analytical specificity and good sensitivity. Here, we want to give an overview over current fit-for-purpose assays for MS-based protein quantification. Advantages as well as challenges of this approach will be discussed with focus on feasibility for routine diagnostic use.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Mass spectrometry; Protein quantification

Mesh:

Substances:

Year:  2016        PMID: 27061318     DOI: 10.1002/prca.201500116

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  11 in total

Review 1.  Fluid biomarkers for mild traumatic brain injury and related conditions.

Authors:  Henrik Zetterberg; Kaj Blennow
Journal:  Nat Rev Neurol       Date:  2016-09-16       Impact factor: 42.937

Review 2.  Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-02-13       Impact factor: 4.044

Review 3.  Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.

Authors:  Abdellah Tebani; Carlos Afonso; Stéphane Marret; Soumeya Bekri
Journal:  Int J Mol Sci       Date:  2016-09-14       Impact factor: 5.923

4.  Personalized Proteomics: The Future of Precision Medicine.

Authors:  Trevor T Duarte; Charles T Spencer
Journal:  Proteomes       Date:  2016-10-01

Review 5.  Proteomics progresses in microbial physiology and clinical antimicrobial therapy.

Authors:  B Chen; D Zhang; X Wang; W Ma; S Deng; P Zhang; H Zhu; N Xu; S Liang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-04       Impact factor: 3.267

6.  Serum Steroid Ratio Profiles in Prostate Cancer: A New Diagnostic Tool Toward a Personalized Medicine Approach.

Authors:  Adriana Albini; Antonino Bruno; Barbara Bassani; Gioacchino D'Ambrosio; Giuseppe Pelosi; Paolo Consonni; Laura Castellani; Matteo Conti; Simone Cristoni; Douglas M Noonan
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-05       Impact factor: 5.555

7.  Needle lost in the haystack: multiple reaction monitoring fails to detect Treponema pallidum candidate protein biomarkers in plasma and urine samples from individuals with syphilis.

Authors:  Geert A Van Raemdonck; Kara K Osbak; Xaveer Van Ostade; Chris R Kenyon
Journal:  F1000Res       Date:  2018-03-19

8.  Accurate Detection of the Four Most Prevalent Carbapenemases in E. coli and K. pneumoniae by High-Resolution Mass Spectrometry.

Authors:  Dimard E Foudraine; Lennard J M Dekker; Nikolaos Strepis; Michiel L Bexkens; Corné H W Klaassen; Theo M Luider; Wil H F Goessens
Journal:  Front Microbiol       Date:  2019-11-26       Impact factor: 5.640

Review 9.  Towards Precision Dermatology: Emerging Role of Proteomic Analysis of the Skin.

Authors:  Gabriella Fredman; Lone Skov; Matthias Mann; Beatrice Dyring-Andersen
Journal:  Dermatology       Date:  2021-06-01       Impact factor: 5.366

10.  Plasma protein absolute quantification by nano-LC Q-TOF UDMSE for clinical biomarker verification.

Authors:  Maria Ilies; Cristina Adela Iuga; Felicia Loghin; Vishnu Mukund Dhople; Elke Hammer
Journal:  Clujul Med       Date:  2017-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.